Cargando…
Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
Non-genetic factors are crucial in the pathogenesis of type 1 diabetes (T1D), a disease caused by autoimmunity against insulin-producing β-cells. Exposure to medications in the prenatal period may influence the immune system maturation, thus altering self-tolerance. Prenatal administration of betame...
Autores principales: | Perna-Barrull, David, Rodriguez-Fernandez, Silvia, Pujol-Autonell, Irma, Gieras, Anna, Ampudia-Carrasco, Rosa M., Villalba, Adrian, Glau, Laura, Tolosa, Eva, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362293/ https://www.ncbi.nlm.nih.gov/pubmed/30718757 http://dx.doi.org/10.1038/s41598-018-37878-9 |
Ejemplares similares
-
Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes
por: Perna-Barrull, David, et al.
Publicado: (2020) -
Prenatal Administration of Betamethasone Causes Changes in the T Cell Receptor Repertoire Influencing Development of Autoimmunity
por: Gieras, Anna, et al.
Publicado: (2017) -
Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells
por: Perna-Barrull, David, et al.
Publicado: (2022) -
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
por: Villalba, Adrian, et al.
Publicado: (2020) -
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
por: Villalba, Adrian, et al.
Publicado: (2020)